Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0494-2025Class II

Abbott Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 27 mm, NVRO-27, Sterile

Abbott Medical / initiated 2024-10-17 / Open, Classified / root cause: manufacturing process

Abbott Medical began a recall of Abbott Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 27 mm, NVRO-27, Sterile on . FDA classified it as Class II and gives the reason as "A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0494-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Abbott Medical
Product
Abbott Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 27 mm, NVRO-27, Sterile
Product code
NPT Aortic Valve, Prosthesis, Percutaneously Delivered
Reason for recall
A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
A Medical Device Recall letter was hand delivered Oct. 21, 2024 to the one US consignee for 1 Impacted Valve. Nine foreign consignees were also notified for 26 Impacted Valves distributed outside of the United States (OUS). Customers are advised to return any remaining unused Impacted Valves, if applicable, and complete and return the accompanying Acknowledgement Form to Abbott. Abbott is executing further testing to verify that long-term durability of the Impacted Valves has not been affected and will communicate any changes to the recommendations set forth in this letter if needed by Q4 2025. In the interim, Abbott recommends continuing the same local standard of care in patients implanted with the Impacted Valve as would be used with patients implanted with any other transcatheter aortic valve implant. If you have any questions, please contact your local Sales Representative or Abbott Support at 1-800-544-1664 (Option 2).
Quantity in commerce
8 OUS
Distribution
New York, Australia, Belgium, Germany, Iran, Israel, Japan, Kazakhstan, Oman, Poland, Romania, Slovakia, Spain, Turkey, United Kingdom.
Product codes and lots
UDI-DI (GTIN): 5415067045799, Serial Numbers: 20158135, 20172203, 20183968, 20184552, 20184670, 20184675, 20190249, & 20213055.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0494-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0491-2025Class IIOngoingVoluntary: Firm initiated
Z-0492-2025Class IIOngoingVoluntary: Firm initiated
Z-0493-2025Class IIOngoingVoluntary: Firm initiated
Z-0494-2025Class IIOngoingVoluntary: Firm initiated
Z-0495-2025Class IIOngoingVoluntary: Firm initiated